Two interconnected brain areas — the hippocampus and the entorhinal cortex — help us to know where we are and to remember it later.
By studying these brain areas, researchers at Baylor College of Medicine, Rice University, The University of Texas MD Anderson Cancer Center and the National Cancer Institute have uncovered new information about how dysfunction of this circuit may contribute to memory loss in Alzheimer’s disease. Their results appear in Cell Reports.
“We created a new mouse model in which we showed that spatial memory decays when the entorhinal cortex is not functioning properly,” said co-corresponding author Dr. Joanna Jankowsky, associate professor of neuroscience at Baylor. “I think of the entorhinal area as a funnel. It takes information from other sensory cortices — the parts of the brain responsible for vision, hearing, smell, touch, and taste — and funnels it into the hippocampus.
“The hippocampus then binds this disparate information into a cohesive memory that can be reactivated in full by recalling only one part,” she added. “But the hippocampus also plays a role in spatial navigation by telling us where we are in the world. These two functions converge in the same cells, and our study set out to examine this duality.”
The new mouse model was genetically engineered to carry a particular surface receptor on the cells of the entorhinal cortex. When this receptor was activated by administering the drug ivermectin to the mice, the cells of the entorhinal cortex silenced their activity. They stopped funneling information to the hippocampus. This system allowed the scientists to turn off the entorhinal cortex, and to determine how this affected hippocampal function.
“We know that the hippocampal neurons generate pulses of activity when the animal is in a particular space,” said co-corresponding author Dr. Daoyun Ji, assistant professor of molecular and cell biology at Baylor.
To measure the electrical activity in the hippocampus, the researchers inserted tiny probes — thinner than a human hair — into the brains of mice.
“We inserted the probes into the hippocampus where they could detect the electrical signal generated by active neurons,” Ji said. “We recorded this signal while the animal explored its surroundings. As the mouse learned its environment, we picked up the electrical pulses produced by the neurons — up to 50 neurons simultaneously — so that we could examine the pattern that emerged. When the animal was in one area of the room, a particular brain pattern emerged. The pattern changed as the animal moved to another area. We could predict where the animal was by looking at its pattern of brain activity.”
When the researchers turned off the entorhinal cortex with ivermectin, they saw the pattern of electrical signals in the hippocampus changed. Signals that had previously been associated with a particular location now became active in a different part of the room.
“We found that the hippocampus had remapped, the memory code was scrambled,” said Ji.
But would mice whose mental map had rearranged itself also lose their memory for the location they learned before re-mapping?
To answer the question, the researchers trained mice to find a hidden escape platform submerged in a water maze using visual clues. Then some of the mice received ivermectin to inactivate the entorhinal cortex, while others did not.
“The mice had been trained for seven to 10 days, so they knew where to go to escape the pool. But when we turned off the entorhinal cortex, their hippocampal map got scrambled and the animals couldn’t remember how to exit the pool,” said Ji.
According to Jankowsky, the findings put the team one step closer to understanding how the hippocampus may be required not only to learn a new environment, but also to remember it later. said Jankowsky.
“The system we used to silence neurons with ivermectin adds to a growing set of genetic tools created over the last 10 years to probe brain function,” she added. “Because ivermectin is both safe and inexpensive, this particular system can be used for longer periods of inactivation appropriate for studying chronic conditions like Alzheimer’s or Parkinson’s. That’s the thing I am most excited about with this work.”
